Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Pierre-Olivier Blotière"'
Autor:
Joël Coste, Hugo Peyre, Yann Mikaeloff, Pierre Olivier Blotière, Rosemary Dray-Spira, Alain Weill, Zureik Mahmoud, Sara Miranda, Franck Ramus
Publikováno v:
BMJ Open
BMJ Open, BMJ Publishing Group, 2020, 10 (6), pp.e034829. ⟨10.1136/bmjopen-2019-034829⟩
BMJ Open, BMJ Publishing Group, 2020, 10 (6), pp.e034829. ⟨10.1136/bmjopen-2019-034829⟩
ObjectivesTo assess the association between prenatal exposure to monotherapy with the antiepileptic drugs (AEDs) most commonly used during pregnancy and the risk of various neurodevelopmental outcomes compared with lamotrigine.DesignNationwide popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aeb2dbbb0ca9ad1e23b83000d4f2c92
https://hal.archives-ouvertes.fr/hal-02876620
https://hal.archives-ouvertes.fr/hal-02876620
Autor:
Véronique Goulet, Joël Coste, Fanny Raguideau, Mahmoud Zureik, Pierre-Olivier Blotière, Florence Rouget, Elisabeth Elefant, Rosemary Dray-Spira, Isabelle Perthus, Alain Weill
Publikováno v:
Neurology
Neurology, American Academy of Neurology, 2019, 93 (2), pp.e167-e180. ⟨10.1212/WNL.0000000000007696⟩
Neurology, 2019, 93 (2), pp.e167-e180. ⟨10.1212/WNL.0000000000007696⟩
Neurology, American Academy of Neurology, 2019, 93 (2), pp.e167-e180. ⟨10.1212/WNL.0000000000007696⟩
Neurology, 2019, 93 (2), pp.e167-e180. ⟨10.1212/WNL.0000000000007696⟩
ObjectiveTo assess the association between exposure to monotherapy with 10 different antiepileptic drugs (AEDs) during the first 2 months of pregnancy and the risk of 23 major congenital malformations (MCMs).MethodsThis nationwide cohort study, based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f19ab115e6d8f146c1aa63d18f22a608
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02179394
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02179394
Autor:
Mahmoud Zureik, Joël Coste, Fanny Raguideau, Rosemary Dray-Spira, Alain Weill, M. Mezzarobba, Marie Dalichampt, Pierre-Olivier Blotière, Cécile Billionnet, François Alla
Publikováno v:
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, Wiley, 2018, 27 (7), pp.763-770. ⟨10.1002/pds.4556⟩
Pharmacoepidemiology and Drug Safety, Wiley, 2018, 27 (7), pp.763-770. ⟨10.1002/pds.4556⟩
Purpose Access to claims databases provides an opportunity to study medication use and safety during pregnancy. We developed an algorithm to identify pregnancy episodes in the French health care databases and applied it to study antiepileptic drug (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92bba1f53b014012ade6bac72605e02b
http://hdl.handle.net/20.500.12278/11471
http://hdl.handle.net/20.500.12278/11471
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 17(4)
Background & Aims We investigated perforations, bleeding, and splenic injuries after screening or diagnostic colonoscopies to identify patient-, procedure-, endoscopist-, and facility-associated risk factors. Methods We analyzed data from the SNIIRAM
Autor:
Mahmoud Zureik, Géric Maura, Pierre-Olivier Blotière, Philippe Ricordeau, François Alla, Cécile Billionnet, Kim Bouillon
Publikováno v:
Circulation. 132:1252-1260
Background— The safety and effectiveness of non–vitamin K antagonist (VKA) oral anticoagulants, dabigatran or rivaroxaban, were compared with VKA in anticoagulant-naive patients with nonvalvular atrial fibrillation during the early phase of antic
Autor:
Géric Maura, Philippe Ricordeau, Mahmoud Zureik, Pierre-Olivier Blotière, Kim Bouillon, Marion Bertrand
Publikováno v:
The Lancet Haematology. 2:e150-e159
Summary Background Patients with non-valvular atrial fibrillation who are receiving or have been previously exposed to a vitamin K antagonist could be switched to a non-vitamin K-antagonist oral anticoagulant (NOAC) but little information is availabl
Autor:
François Alla, Jean-Paul Fagot, Hubert Allemand, Alain Weill, Philippe Ricordeau, Pierre-Olivier Blotière
Publikováno v:
Diabetes Care. 36:294-301
OBJECTIVE To explore in France the relationship between insulin glargine use and overall and specific cancer risks in type 2 diabetic patients compared with other basal insulins. RESEARCH DESIGN AND METHODS Data were extracted from French health insu
Autor:
Mahmoud Zureik, Jérémie Rudant, Marie Dalichampt, Philippe Ricordeau, François Alla, Fanny Raguideau, Alain Weill, Pierre-Olivier Blotière
Publikováno v:
BMJ (Clinical research ed.). 353
Objective To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial infarction associated with combined oral contraceptives according to dose of oestrogen (ethinylestradiol) and progestogen. Design Observational cohort study. Setting
Autor:
Pierre-Olivier Blotière, Christophe Chaignot, Aurélie Bannay, François Alla, Alain Weill, Philippe Ricordeau, Mickael Basson
Publikováno v:
Medical Care
Medical Care, American Public Health Association, 2016, 54 (2), pp.188-194. ⟨10.1097/MLR.0000000000000471⟩
Medical Care, 2016, 54 (2), pp.188-194. ⟨10.1097/MLR.0000000000000471⟩
Medical Care, American Public Health Association, 2016, 54 (2), pp.188-194. ⟨10.1097/MLR.0000000000000471⟩
Medical Care, 2016, 54 (2), pp.188-194. ⟨10.1097/MLR.0000000000000471⟩
International audience; BACKGROUND:The most used score to measure comorbidity is the Charlson index. Its application to a health care administrative database including International Classification of Diseases, 10th edition (ICD-10) codes, medical pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572b0dd037255a263552d224a52bd8e5
https://hal.univ-lorraine.fr/hal-01817541
https://hal.univ-lorraine.fr/hal-01817541
Autor:
Alain Weill, Pierre-Olivier Blotière, Amélie Barré, Laurent Peyrin-Biroulet, Jérémie Rudant, François Alla, Antoine Racine, Franck Carbonnel
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, WB Saunders, 2016, 48 (6), pp.620-625. ⟨10.1016/j.dld.2016.02.022⟩
Digestive and Liver Disease, WB Saunders, 2016, 48 (6), pp.620-625. ⟨10.1016/j.dld.2016.02.022⟩
International audience; Background: Tumour necrosis factor inhibitors (anti-TNFs) are active but expensive drugs that induce and maintain remission in patients with Crohn's disease (CD) and ulcerative colitis (UC). Aims: To assess the trends in anti-